Print

Valeant Pharmaceuticals International (VRX) to Present at Deutsche Bank (DB) Securities, Inc. 37th Annual Health Care Conference  
4/30/2012 9:37:17 AM

MONTREAL, April 27, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:50 p.m. ET. The conference will be held at the InterContinental Hotel in Boston.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://www.media-server.com/m/p/4c46bofr

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE:VRX/TSX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact:
Laurie Little
Valeant Pharmaceuticals
949-461-6002

SOURCE Valeant Pharmaceuticals International, Inc.


//-->